Screening of the miRNAs related to breast cancer and identification of its target genes

European Journal of Gynaecological Oncology

Volumn 35, Issue 6, 2014, Pages 696-700

  Sun, Xianfu ^a   Luo, Suxia ^a   He, Yaning ^a   Shao, Yingbo ^a   Liu, Chaojun ^a   Chen, Qi ^a   Cui, Shude ^a   Liu, Hui ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Breast cancer; Microarray; MiR 200c; MiR 21; MiRNAs; Target gene

Indexed keywords

FIREFLY LUCIFERASE; MICRORNA; MICRORNA 122; MICRORNA 1261; MICRORNA 1270; MICRORNA 1299; MICRORNA 16 2; MICRORNA 200C; MICRORNA 208A; MICRORNA 208B; MICRORNA 21; MICRORNA 25; MICRORNA 299 3P; MICRORNA 300; MICRORNA 30E; MICRORNA 485 3P; MICRORNA 490 3P; MICRORNA 498; MICRORNA 519E; MICRORNA 630; MICRORNA 938; MICRORNA LET 518E; MICRORNA LET 7A 2; PDCD4 PROTEIN; PROTEIN; RENILLA LUCIFERIN 2 MONOOXYGENASE; SMAD7 PROTEIN; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; LUCIFERASE; MEMBRANE PROTEIN; MIRN200 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; ONCOPROTEIN; PDCD10 PROTEIN, HUMAN; PDCD4 PROTEIN, HUMAN; RNA BINDING PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; BREAST CANCER; BREAST CANCER CELL LINE; BREAST EPITHELIUM CELL; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE TARGETING; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PREDICTION; RNA EXTRACTION; UPREGULATION; BREAST; BREAST TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PRECANCER; TUMOR CELL LINE;

APOPTOSIS REGULATORY PROTEINS; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUCIFERASES; MEMBRANE PROTEINS; MICRORNAS; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS; RNA-BINDING PROTEINS;

EID: 84925222927     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: 10.12892/ejgo25212014     Document Type: Article

References (24)

1. Lee, R. C., Feinbaum, R. L., Ambros, V.: "The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14". Cell, 1993, 75, 843.
2. Matejuk A., Collet G., Nadim M., Grillon C., Kieda C.: "MicroRNAs and tumor vasculature normalization: impact on anti-tumor immune response". Arch. Immunol. Ther. Exp. (Warsz), 2013, 61, 285.
3. Dassow H., Aigner A.: "MicroRNAs (miRNAs) in colorectal cancer: from aberrant expression towards therapy". Curr. Pharm. Des., 2013, 19, 1242.
4. Wang Z., Zhang H., He L., Dong W., Li J., Shan Z., Teng W.: "Association between the expression of four upregulated miRNAs and extrathyroidal invasion in papillary thyroid carcinoma". Onco. Targets Ther., 2013, 6, 281.
5. Gamez B., Rodriguez-Carballo E., Bartrons R., Rosa J. L., Ventura F.: "miR-322 and its target Tob2 modulate Osterix mRNA stability". J. Biol. Chem., 2013, 288, 14264.
6. Cronin-Fenton D. P., Norgaard M., Jacobsen J., Garne J. P., Ewertz M., Lash T. L., et al.: "Comorbidity and survival of Danish breast cancer patients from 1995 to 2005". Br. J. Cancer, 2007, 96, 1462.
7. Pellegrino L., Stebbing J., Braga V. M., Frampton A. E., Jacob J., Buluwela L., et al.: "miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts". Nucleic Acids Res., 2013, 41, 5400
8. Stone A., Valdés-Mora F., Gee J. M., Farrow L., McClelland R. A., Fiegl H., et al.: "Tamoxifen-induced epigenetic silencing of oestrogenregulated genes in anti-hormone resistant breast cancer". PLoS One, 2012, 7, e40466.
9. Han M., Liu M., Wang Y., Chen X., Xu J., Sun Y., et al.: "Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN". PLoS One, 2012, 7, e39520.
10. Okuda H., Kobayashi A., Xia B., Watabe M., Pai S. K., Hirota S., et al.: "Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells". Cancer Res., 2012, 72, 537.
11. Wittekindt C., Wagner S., Mayer C. S., Klussmann J. P.: "Basics of tumor development and importantance of human papilloma virus (HPV) for head and neck cancer". GMS Curr. Top Otorhinolaryngol. Head Neck Surg., 2012, 11, Doc09.
12. Wagner S., Willenbrock S., Nolte I., Murua Escobar H.: "Comparison of non-coding RNAs in human and canine cancer". Front Genet., 2013;4, 46. doi: 10.3389/fgene.2013.00046.
13. Kraggerud S. M., Hoei-Hansen C. E., Alagaratnam S., Skotheim R. I., Abeler V. M., Rajpert-De Meyts E., et al.: "Molecular chatacteristics of malignant ovarian germ cell tumors and comparison with testicular counterpats: implications for pathogenesis". Endocr. Rev, 2013, 34, 339.
14. Zhi F., Dong H., Jia X., Guo W., Lu H., Yang Y., et al.: "Functionalized grapheme oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitro". PLoS One, 2013, 8, e60034.
15. Chen L., Li Y., Fu Y., Peng J., Mo M. H., Stamatakos M., et al.: "Role of deregulated micro RNAs in breast cancer progression using FFPE tissue". PLoS One, 2013, 8, e54213.
16. Kopp F., Oak P. S., Wagner E., Roidl A.: "miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression". PLoS One, 2012, 7, e50469.
17. Wang S., Huang J., Lyu H., Lee C. K., Tan J., Wang J., et al.: "Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostatinduced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells". Cell Death Dis., 2013, 4, e556.
18. Bartel D. P.: "MicroRNAs: genomics, biogenesis, mechanism, and function". Cell, 2004, 116, 281.
19. Yan L. X., Huang X. F., Shao Q., Huang M. Y., Deng L., Wu Q. L., et al.: "MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis". RNA, 2008, 14, 2348.
20. Qian B., Katsaros D., Lu L., Preti M., Durando A., Arisio R., et al.: "High miR-21 expression in breast cancer associated with poor diseasefree survival in early stage disease and high TGF-betal". Breast Cancer Res. Treat., 2009, 117, 131.
21. Di Leva G., Piovan C., Gasparini P., Ngankeu A., Taccioli C., Briskin D., et al.: "Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status". PLoS Genet., 2013, 9, e1003311.
22. Jin C., Rajabi H., Rodrigo C. M., Porco J. A. Jr., Kufe D. Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein. Oncogene, 2012, 32, 2179. doi: 10.1038/onc.2012.236. Epub 2012 Jun. 11.
23. Aguirre A. J., Brennan C., Bailey G., Sinha R., Feng B., Leo C., et al.: "High-resolution characterization of the pancreatic adenocarcinoma genome". Proc. Natl. Acad. Sci. USA, 2004, 1001, 9067.
24. Huerta S., Harris D. M., Jazirehi A., Bonavida B., Elashoff D., Livingston E. H., et al.: "Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis". Int. J. Oncol., 2003, 22, 663.